home All News open_in_new Full Article

Idorsia mit positiven Studiendaten für Impfstoff gegen Darmbakterium C.difficile

Pharma - Das Biotechunternehmen Idorsia publiziert ermutigende Studiendaten für einen möglichen Impfstoff gegen das Darmbakterium und Sporen des Typs Clostridioides difficile (C.difficile).


today 5 d. ago attach_file Other

attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Society
attach_file Other
attach_file Other
attach_file Other
attach_file Events
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other


ID: 3403785803
Add Watch Country

arrow_drop_down